Evidence that tirzepatide protects against diabetes-related cardiac damages

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective antidiabetic drugs with potential cardiovascular benefits. Despite their well-established role in reducing the risk of major adverse cardiovas...

Source: Cardiovascular Diabetology - March 30, 2024 Category: Cardiology Authors: Fatemeh Taktaz, Lucia Scisciola, Rosaria Anna Fontanella, Ada Pesapane, Puja Ghosh, Martina Franzese, Giovanni Tortorella, Armando Puocci, Eduardo Sommella, Giuseppe Signoriello, Fabiola Olivieri, Michelangela Barbieri and Giuseppe Paolisso Tags: Research Source Type: research